Orient Pharma (Taiwan) Investor Sentiment

4166 Stock  TWD 37.00  0.05  0.14%   
Slightly above 51% of Orient Pharma's investor base is interested to short. The analysis of current outlook of investing in Orient Pharma Co suggests that many traders are impartial regarding Orient Pharma's prospects. Orient Pharma's investing sentiment can be driven by a variety of factors including economic data, Orient Pharma's earnings reports, geopolitical events, and overall market trends.
Orient Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orient daily returns and investor perception about the current price of Orient Pharma Co as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
This recently listed IT stock zoomed 101 percent over IPO price up 48 percent in 5 days - Business S...
Google News at Macroaxis
over a month ago at news.google.com         
Orient Technologies Share Price Today on 05-11-2024 Orient Technologies share price are up by 15.31,...
Google News at Macroaxis
over two months ago at news.google.com         
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces...
Google News at Macroaxis
over three months ago at news.google.com         
The pharmaceutical market in the Republic of Moldova Significant growth and consolidation of market ...
Google News at Macroaxis
over three months ago at news.google.com         
Orient Technologies shares make strong stock market debut shares list at 41 percent premium - Busine...
Google News at Macroaxis
over three months ago at news.google.com         
Orient Tech shares hit 5 percent upper circuit on BSE up 48 percent from IPO price - Business Standa...
Google News at Macroaxis
over three months ago at news.google.com         
This Mukul Agrawal-owned smallcap stock has zoomed 57 percent in 4 days - Business Standard
Google News at Macroaxis
over three months ago at news.google.com         
Stock Market Today All You Need To Know Going Into Trade On July 30 - NDTV Profit
Google News at Macroaxis
over three months ago at news.google.com         
Share Market Highlights 10 July 2024 Sensex falls over 500 points from record high MM and IT stocks ...
Google News at Macroaxis
over three months ago at news.google.com         
Upcoming IPOs Akums Drugs, Orient Tech, 2 other firms get SEBI nod to float public offers - Zee Busi...
Google News at Macroaxis
over three months ago at news.google.com         
Akums Drugs, Gold Plus Glass, Ceigall, Orient Tech get SEBI nod to launch IPO - Fortune India
Google News at Macroaxis
over three months ago at news.google.com         
Orient Cement shares zoom 47 percent in a month heres what analysts say - Business Today
Google News at Macroaxis
over three months ago at news.google.com         
Orient Cement shares extend gains, zoom 20 percent to hit fresh record high - Business Today
Google News at Macroaxis
over six months ago at news.google.com         
Q4 results ONGC, ITC, NTPC, Sun Pharma, Nykaa among companies to declare earnings this week Company ...
Google News at Macroaxis
over six months ago at news.google.com         
Q4 results this week ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC - The Economic Times
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Orient Pharma that are available to investors today. That information is available publicly through Orient media outlets and privately through word of mouth or via Orient internal channels. However, regardless of the origin, that massive amount of Orient data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Orient Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Orient Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Orient Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Orient Pharma alpha.

Orient Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Orient Stock Analysis

When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.